Learn how a large, multi-site study supports laboratory adoption of extragenital CT/NG testing on an automated, high throughput platform. This episode reviews importance of extragenital sample collection for STI testing, performance of extragenital STI testing on the BD COR™ System, and operational benefits of high-throughput automation.


Disclaimer: Waters Corporation has acquired BD [Biosciences/Diagnostic Solutions]. BD remains the legal manufacturer until all required regulatory transfers are complete. Learn more: www.waters.com/bdtransaction 

Rss
Podden och tillhörande omslagsbild på den här sidan tillhör BD Molecular Diagnostics. Innehållet i podden är skapat av BD Molecular Diagnostics och inte av, eller tillsammans med, Poddtoppen.